The post FDA to review Kowa Pharmaceuticals’ NDA for glaucoma eye drop K-911 appeared first on Hospital Management.
FDA to review Kowa Pharmaceuticals’ NDA for glaucoma eye drop K-911
Hospital Management
·
·
7 views
The US FDA is set to review Kowa Pharmaceuticals America’s NDA for K-911, an investigational once-daily eye drop aimed at IOP in OAG or OHT patients. The post FDA to review Kowa Pharmaceuticals’ NDA for glaucoma eye drop K-911 appeared first on Hospital Management.
Coffee With Kenobi » Audiobook Reviews 
Equally Ours » Gender 
Forces of Geek 
Inc. Magazine 
Cheezyfeet Books 
The Babbit's Grimoire 
